// App-Quantinova.ai

e21100 : Correlation between the TTF-1 expression and immune-related thyroid dysfunction and efficacy of anti-PD1 treatment in non-small cell lung cancer.

Researchers

Presenter

  • Junji Koyama

Principal Investigators

  • Atsushi Horiike

  • Takahiro Yoshizawa

  • Yosuke Dotsu

  • Ryo Ariyasu

  • Masafumi Saiki

  • Tomoaki Sonoda

  • Ken Uchibori

  • Shingo Nishikawa

  • Satoru Kitazono

  • Noriko Yanagitani

  • Hironori Ninomiya

  • Yuichi Ishikawa

  • Makoto Nishio

Medical Centers

  • Department of Pharmacy,The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

  • Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan

  • Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Transcription termination factor 1

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved